Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Leichner

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Radiology|October 1, 1981
Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32pP K Leichner, S A Cash, C Backx, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Patient-specific dosimetry using quantitative SPECT imaging and three-dimensional discrete Fourier transform convolutionG Akabani, W G Hawkins, M B Eckblade, et al.
Radiology|March 1, 1980
Distribution and tissue dose of intraperitoneally administered radioactive chromic phosphate (32P) in New Zealand white rabbitsP K Leichner, N B Rosenshein, S A Leibel, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1984
Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatomaR A Rostock, J L Klein, P K Leichner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1993
Evaluation of indium-111- and yttrium-90-labeled linker-immunoconjugates in nude mice and dogsS M Quadri, H M Vriesendorp, P K Leichner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1986
Detection of specific anti-antibodies in patients treated with radiolabeled antibodyJ L Klein, J W Sandoz, K A Kopher, et al.
Oncology (Williston Park, N.Y.)|May 1, 1989
Current status of radioimmunoglobulins in the treatment of human malignancyS E Order, A M Sleeper, G B Stillwagon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatmentJ M Herpst, J L Klein, P K Leichner, et al.
Cancer Research|February 1, 1990
Radiolabeled antibodies: results and potential in cancer therapyS E Order, A M Sleeper, G B Stillwagon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1989
Polyclonal 90Yttrium labeled antiferritin for refractory Hodgkin's diseaseH M Vriesendorp, J M Herpst, P K Leichner, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Radiology|October 1, 1981
Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32pP K Leichner, S A Cash, C Backx, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Patient-specific dosimetry using quantitative SPECT imaging and three-dimensional discrete Fourier transform convolutionG Akabani, W G Hawkins, M B Eckblade, et al.
Radiology|March 1, 1980
Distribution and tissue dose of intraperitoneally administered radioactive chromic phosphate (32P) in New Zealand white rabbitsP K Leichner, N B Rosenshein, S A Leibel, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1984
Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatomaR A Rostock, J L Klein, P K Leichner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1993
Evaluation of indium-111- and yttrium-90-labeled linker-immunoconjugates in nude mice and dogsS M Quadri, H M Vriesendorp, P K Leichner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1986
Detection of specific anti-antibodies in patients treated with radiolabeled antibodyJ L Klein, J W Sandoz, K A Kopher, et al.
Oncology (Williston Park, N.Y.)|May 1, 1989
Current status of radioimmunoglobulins in the treatment of human malignancyS E Order, A M Sleeper, G B Stillwagon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatmentJ M Herpst, J L Klein, P K Leichner, et al.
Cancer Research|February 1, 1990
Radiolabeled antibodies: results and potential in cancer therapyS E Order, A M Sleeper, G B Stillwagon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1989
Polyclonal 90Yttrium labeled antiferritin for refractory Hodgkin's diseaseH M Vriesendorp, J M Herpst, P K Leichner, et al.
Pageof 6